Stay updated on Cemiplimab in NSCLC: European Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.

Latest updates to the Cemiplimab in NSCLC: European Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new version entry: Revision: v3.4.2. Removed the funding-status notice and the prior Revision: v3.4.1 entry.SummaryDifference0.7%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding is now displayed. The footer revision tag has been updated from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check28 days agoChange DetectedThe update adds UI enhancements to the record history, including a glossary toggle, green highlights for additions, red highlights for deletions, and a new revision label (v3.4.0). These changes do not modify the underlying study data.SummaryDifference0.9%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor site version change with no impact on study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new history entry 'Revision: v3.3.3' was added and the footer now omits 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded new entries for Study Status and Contacts/Locations on 2025-12-09, tied to version 19 from 2025-12-02. These updates reflect the current recruitment status and the study's locations and contacts in the record history.SummaryDifference0.4%

Stay in the know with updates to Cemiplimab in NSCLC: European Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.